Microlax

Sodium Citrate and Sodium Lauryl Sulfoacetate, the active ingredients in Microlax, are laxatives presented as an unspecified strength rectal solution (enema) for rectal use. They provide rapid relief of occasional constipation and are employed to empty the bowel before diagnostic procedures in adults and children under medical supervision. The formulation is designed for quick onset of action, typically producing a bowel movement within minutes after administration.

GNH USA supplies Microlax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets.

Microlax, an osmotic and stimulant laxative, is used to manage conditions that require rapid bowel emptying, particularly when a swift and reliable effect is needed. - Occasional constipation: provides quick softening of stool and facilitates evacuation. - Diagnostic bowel preparation: clears the colon promptly before procedures such as colonoscopy or radiographic imaging. - Acute bowel retention: offers rapid relief for sudden episodes of bowel blockage in adults. - Pre‑operative preparation: empties the rectum before surgery to reduce infection risk. - Travel‑related constipation: helps travelers experiencing temporary bowel slowdown.

Microlax may generally cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mild abdominal cramping: discomfort in the lower abdomen after administration. - Rectal irritation: transient burning or itching at the application site. - Loose stools or diarrhea: increased frequency of watery bowel movements. - Nausea: occasional feeling of queasiness. - Flatulence: temporary gas buildup after use. - Headache: mild headache reported by some users.

Serious or Rare Side Effects: - Severe abdominal pain: intense, persistent pain that may indicate intestinal obstruction and requires immediate medical evaluation. - Rectal bleeding: unexpected bleeding from the rectal mucosa. - Allergic reaction: rash, swelling, or difficulty breathing.

Before using Microlax, consider the following precautions to ensure safe and effective use. - Contraindication: Do not use in patients with known hypersensitivity to any component. - Bowel obstruction: Avoid if there is a mechanical blockage of the intestine. - Inflammatory bowel disease: Use with caution in active ulcerative colitis or Crohn’s disease. - Pregnancy and lactation: Consult a healthcare professional before use, as safety data are limited. - Pediatric use: Use only under medical supervision for children, dosing may differ. - Store at room temperature: Keep the enema in its original container, protect from light and moisture.

Microlax can interact with certain medications or substances, influencing their absorption or effect.

Major Interactions (Avoid): - Antidiarrheal agents (e.g., loperamide): may counteract the laxative effect. - Oral electrolyte supplements: rectal administration can alter electrolyte balance, requiring monitoring.

Moderate Interactions (Monitor Closely): - Oral medications with narrow therapeutic index: rapid bowel evacuation may affect absorption timing. - Intravenous fluids containing electrolytes: concurrent use may affect overall electrolyte status. - Herbal laxatives or bulk‑forming agents: combined use may increase risk of abdominal discomfort.